垂体腺瘤侵袭性相关因子的研究进展
摘要
垂体腺瘤是神经-内分泌系统的常见疾病,发病率约为1/10万,生前无任何表现,尸检时才发现有垂体腺瘤者并非少见,尸检发现率约为11%;垂体腺瘤发病率约占颅内肿瘤的10%～15%。垂体腺瘤分侵袭性和非侵袭性两种,非侵袭性垂体腺瘤为良性肿瘤;
出处
《重庆医学》
CAS
CSCD
北大核心
2011年第18期1849-1851,共3页
Chongqing medicine
参考文献25
-
1Suhardja A,Kovacs K,Rutka J.Genetic basis of pituitary adenoma invasiveness a review[J].J Neurooncol,2001,52(3):195-204.
-
2Neto AG,McCutcheon IE,Vang R,et al.Elevated expression of p21 (WAF1/Cip1) in hormonally active pituitary adenomas[J].Ann Diagn Pathol,2005,9(1):6-10.
-
3Giacomini D,Páez-Pereda M,Refojo D,et al.New mechanisms involved in the pathogenesis of pituitary adenomas[J].Medicina(B Aires),2003,63(2):147-150.
-
4Salehi F,Kovacs K,Scheithauer BW,et al.Immunohistochemical expression of pituitary tumor transforming gene (PTTG) in pituitary adenomas:a correlative study of tumor subtypes[J].Int J Surg Pathol,2010,18(1):5-13.
-
5Zhu X,Lee K,Asa SL,et al.Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells[J].Am J Pathol,2007,170(5):1618-1628.
-
6Hussaini IM,Trotter C,Zhao Y,et al.Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line[J].Am J Pathol,2007,170(1):356-365.
-
7Lacmix M,Toillon RA,Leclercq G.p53 and breast can-cer,an update[J].Endocr Relat Cancer,2006,13(2):293-325.
-
8Gejman R,Swearingen B,Hedley-Whyte ET.Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas[J].Hum Pathol,2008,39(5):758-766.
-
9沈晓黎,舒凯,万锋,董芳永,曾令成,雷霆,薛德麟.PCNA、CD_(34)与bcl-2在垂体腺瘤中的表达与生物学行为相关性研究[J].中华神经外科疾病研究杂志,2004,3(6):485-488. 被引量：3
-
10Pan LX,Chen ZP,Liu YS,et al.Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space[J].J Neurooncol,2005,74(1):71-76.
二级参考文献34
-
1章翔,甄海宁.加强垂体腺瘤的基础与临床研究[J].中华神经外科疾病研究杂志,2005,4(5):385-387. 被引量：13
-
2Leplletier Y, Camara-Clayette V, Jin H, et al. Prevention of mantle lymphoma tumor establishment by routing transferrin receptor toward lysosomal compartments[J]. Cancer Res,2007,67 (3) : 1145.
-
3Daniel TR,Delgado T,Rodriguez JA, et al. The transferrin receptor part Ⅰ: biology and targeting with cytotoxic antibodies for the treatment of cancer[J]. Clin Imrnunol, 2006,121(2) :144.
-
4Qing Y,Shuo W,Zhihua W,et al. The in vitro antitumor effect and in vivo tumor-specificity distribution of humanmouse chimeric antibody against transferrin receptor[J]. Cancer Immunol Immunother, 2006,55 ( 9 ) : 1111.
-
5Detmar M. Tumor angiogenesis[J]. J Invest Dermatomol Symp Proc,2000,5(1) :20.
-
6Salven P, Hattori K, Heissig B, et al. Interleukin-1α promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion [J]. FASEB J,2002,16: 1471.
-
7Wei LH,Kuo ML,Chen CA,et al. Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor [J]. Gynecol Oncol,2001,82(1) :49.
-
8Salgado R, Benoy I, Weyutuens R, et al. Aterio-venous gradients of IL-6,plasma and serum VEGF and D-dimers in human cancers[J]. Br J Cancer,2002,87(15):1437.
-
9Benoy I, Salgado R, Colaert C, et al. Serum interleukin-6, plasma VEGF, serum VEGF and VEGF patlet load in breastcancer patients[J]. Clin Breast Cancer, 2002,2:311.
-
10Borg SA,Kerry KE,Royds JA,et al. Correlation of VEGF production with IL-1α and IL-6 secretion by human pituitary adenoma cells [J]. Eur J Endocrinol,2005,152 : 293.
共引文献6
-
1张华楸,雷霆,舒凯,李龄.垂体腺瘤侵袭性相关蛋白研究进展[J].中华神经外科疾病研究杂志,2005,4(5):471-473. 被引量：1
-
2刘小美,方肇勤,潘志强,卢文丽,梁超,吴中华,侯俐,张辉,卓少元,廖明娟,高必峰.荷瘤小鼠虚证、实证垂体基因表达的差异[J].河南中医,2009,29(1):34-38. 被引量：3
-
3张晨冉,孙青芳,卞留贯,赵卫国,沈建康,李娜,李小英,宁光.HIF—1α在小鼠ACTH垂体腺瘤细胞AtT-20的抗凋亡作用[J].中华内分泌代谢杂志,2009,25(5):485-488. 被引量：2
-
4孙鹏鹏,王雪峰,赵鑫,刘晓谦,王智,岳武.MiR-26a在垂体腺瘤中表达的研究[J].中华神经外科杂志,2011,27(9):882-884. 被引量：1
-
5忽平,李红雨,郭小芬,高玉霞,张红岩,贾冬丽,李爱香.卵巢上皮性癌TGFBI基因启动子甲基化与CyclinD1蛋白表达的关系[J].中国肿瘤临床,2011,38(21):1315-1317. 被引量：2
-
6孙敏娴(综述),王中京(审校).复发性垂体腺瘤诊治的研究进展[J].医学临床研究,2013,30(3):571-574. 被引量：4
